내가 좋아할 만한 콘텐츠
We are excited to announce that InVision has received Breakthrough Device Designation from the US FDA for AI enabled liver disease detection from routine echocardiography. invisionmedtech.com/news/liver-dis…
We are excited to announce that both EchoPrime @milos_ai and EchoNet-Measurements @Yuki_Sahashi will be presented at the @ASE360 Scientific Sessions Late Breaking Science session! See you in September at #ASE2025 in Nashville!
InVision Precision Cardiac Amyloid receives FDA clearance. Previously receiving Breakthrough Designation, InVision PCA is an AI-#echofirst algorithm for the detection of AL and ATTR Cardiac Amyloidosis invisionmedtech.com/news/fda-clear…
1/n We are excited to announce EchoPrime – the first echocardiography AI model capable of evaluating a full transthoracic echocardiogram study, identify the most relevant videos, and produce a comprehensive interpretation! Great work lead by @milos_ai, EchoPrime is the largest…
Congratulations to the HELIOS-B investigators! Early recognition of TTR amyloidosis leads to the most effective treatment of this deadly disease. Initiation of therapy at earlier stages lead to an even more dramatic impact on survival and decrease in cardiovascular events!
The results hold nicely across all of the prespecified subgroups. Perhaps the most interesting point here is something that has been seen in other amyloidosis trials as well: there appears to be a larger treatment effect for those diagnosed earlier (NTBNP < or > 2000).
We are excited to announce a new CPT code for AI-enhanced echo for detection of Cardiac Amyloidosis! Yesterday, the AMA has issued new CPT code 0932T, a new Cat 3 CPT code to track InVision Precision Cardiac Amyloid usage starting 1/1/2025. invisionmedtech.com/news/cardiac-a…
Thanks for highlighting our FDA clearance! We are excited to be the only echo AI tested in prospective RCT!
The FDA published its latest Healthcare AI Database last week, featuring a massive 882 AI-enabled medical device clearances, and highlighting some interesting trends in cardiovascular AI. cardiacwire.com/ai-clearances-…
We are proud to announce the FDA 510k clearance of Precision LVEF - the only AI-LVEF algorithm proven to provide time savings and improve clinician accuracy in blinded randomized clinical trial! invisionmedtech.com/news/invision-…
@InVision_AI is excited to participate in the @US_FDA's Total Product Life Cycle Advisory Program. We are excited to work with CRDH and OHT2 to evaluate InVision Cardiac Amyloidosis Screening. Our goal is to develop high-quality, safe, effective SaMD medical devices.
We are thrilled to be funded by the @MooreFound and @KPDOR's AIM-HI initiative to study the deployment of AI to screen for cardiac amyloidosis working with an excellent team of physician scientists across four diverse sites. @Paul_P_Cheng @tygluckman @FarazAhmadMD @SmidtHeart…
We are excited to announce InVision has secured FDA breakthrough device designation for #ai enabled #amyloidosis detection. The AI algorithm integrates information from multiple #echofirst views and is the only peer reviewed algorithm of its kind. invisionmedtech.com/post/fda-break…
We are excited to partner with @AlexionPharma to improve diagnosis of rare diseases, such as cardiac amyloidosis. Artificial intelligence can both improve speed and precision of diagnosis. invisionmedtech.com/post/invision-… @AlexionPharmaUS @AstraZeneca @Amyloidosis_ARC
The only AI tool to be shown to indistinguishable from expert clinicians in blinded study.
United States 트렌드
- 1. Sam Darnold 9,244 posts
- 2. Sanders 28K posts
- 3. Rams 22.1K posts
- 4. Browns 32.5K posts
- 5. Ravens 30.9K posts
- 6. Chiefs 46.3K posts
- 7. Mahomes 13.6K posts
- 8. Lamar 18.5K posts
- 9. Seahawks 22.1K posts
- 10. Riley Moss 3,243 posts
- 11. Broncos 25.2K posts
- 12. Myles Garrett 5,174 posts
- 13. Mark Andrews 3,154 posts
- 14. Tony Romo 2,178 posts
- 15. Gabriel 60.3K posts
- 16. #DawgPound 3,446 posts
- 17. Falcons 33.4K posts
- 18. Kelce 5,874 posts
- 19. Bears 63.4K posts
- 20. Chase 105K posts
내가 좋아할 만한 콘텐츠
Something went wrong.
Something went wrong.